Guangdong Biolight Meditech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 300246?
Owner Type	Number of Shares	Ownership Percentage
Institutions	24,113,428	9.22%
Individual Insiders	78,978,011	30.2%
General Public	158,515,288	60.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 39.41% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
27%	Jinyuan Yan	70,705,185	CN¥473.7m	0%	no data
3.01%	Wanjia Asset Management Co., Ltd.	7,886,166	CN¥52.8m	0%	0.08%
2.48%	Shi Wang	6,497,280	CN¥43.5m	0%	no data
1.47%	Shenzhen Qianhai Eagle Fund Management Co., Ltd.	3,852,887	CN¥25.8m	-8.39%	18.13%
1.13%	Golden Eagle Asset Management Co. Ltd.	2,959,950	CN¥19.8m	0%	0.12%
1.13%	Dacheng Fund Management Co., Ltd.	2,948,450	CN¥19.8m	0%	0.02%
0.77%	China Merchants Fund Management Company Ltd.	2,003,900	CN¥13.4m	0%	0.01%
0.57%	Chuan Ping Yan	1,499,153	CN¥10.0m	-25%	no data
0.55%	CITIC Securities Company Limited, Asset Management Arm	1,436,781	CN¥9.6m	0%	0.01%
0.49%	Huizhou Daya Bay Innovation Investment Management Co., Ltd.	1,276,594	CN¥8.6m	0%	no data
0.45%	Shanghai Shiyu Investment Management Co., Ltd.	1,177,500	CN¥7.9m	0%	100.0%
0.09%	Jinxin Fund Management Co., Ltd.	235,000	CN¥1.6m	0%	0.04%
0.081%	Western Leadbank Fund Management Co., Ltd.	212,550	CN¥1.4m	0%	0.01%
0.058%	Jin Liang	150,721	CN¥1.0m	0%	no data
0.038%	Yongxing Yang	100,480	CN¥673.2k	0%	no data
0.018%	Lion Fund Management Co. Ltd.	48,100	CN¥322.3k	0%	no data
0.012%	Hongde Fund Management Co., Ltd.	30,300	CN¥203.0k	0%	no data
0.0096%	Wei Liao	25,192	CN¥168.8k	0%	no data
0.0053%	Orient Fund Management Co. Ltd.	13,900	CN¥93.1k	0%	no data
0.0044%	Xingyin Fund Management Co., Ltd.	11,600	CN¥77.6k	0%	no data
0.0026%	Fullgoal Fund Management Co. Ltd.	6,800	CN¥45.6k	0%	no data
0.0026%	ICBC Credit Suisse Asset Management Co., Ltd.	6,800	CN¥45.6k	0%	no data
0.0015%	China Universal Asset Management Company Ltd.	3,900	CN¥26.1k	0%	no data
0.00054%	Guotai Asset Management Company Limited	1,400	CN¥9.5k	0%	no data
0.00019%	GF Fund Management Co., Ltd.	500	CN¥3.3k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/27 11:01
End of Day Share Price	2024/12/27 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guangdong Biolight Meditech Co., Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Shuchang Liu	Changjiang Securities Co. LTD.
Peng Zou	China International Capital Corporation Limited
Ling Bo Tu	China Minzu Securities